11 Results for "

SGLT1/2-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (11)

11 Results for "SGLT1/2-IN-1" in MCE Product Catalog:

Cat. No.: HY-138944
CAS No.: 1673514-65-2
Target:  

SGLT

Research Areas:  

Metabolic Disease

SGLT1/2-IN-1 is a dual SGLT1/SGLT2 inhibitor extract from WO2015032272A1, compound 2 .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-10449
CAS No.: 898537-18-3
Purity:  99.33%
Synonyms: TS 071
Target:  

SGLT

Research Areas:  

Metabolic Disease

Luseogliflozin (TS 071) is a potent, selective, orally active sodium-dependent glucose cotransporter (SGLT) 2 inhibitor, with an IC50 of 2.26 nM, about 1765-fold selectivity over SGLT1 (IC50, 3990 nM). Luseogliflozin has the protential for researching type 2 diabetes .
loading...
    loading...
Cat. No.: HY-I1120
CAS No.: 864070-37-1
Target:  

SGLT

Research Areas:  

Metabolic Disease

SGLT2-IN-1 (Compound 5) is an inhibitor for sodium-dependent glucose cotransporter (SGLT2), with IC50 of 33 nM in CHO cells transfected with human SGLT2. SGLT2-IN-1 is selective for SGLT2 over SGLT1. SGLT2-IN-1 is an active metabolite of dapagliflozinactive metabolite of dapagliflozin .
loading...
    loading...
Cat. No.: HY-150322
CAS No.: 702638-25-3
Target:  

SGLT

Research Areas:  

Metabolic Disease

SAR-7226 is a SGLT1 and SGLT2 dual inhibitor. SAR-7226 can be used for research of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-109092A
CAS No.: 2730989-98-5
Synonyms: rel-LIK066
Target:  

SGLT

rel-Licogliflozin is a relative configuration of Licogliflozin (HY-109092). Licogliflozin is a sodium glucose cotransporter (SGLT1 and SGLT2) inhibitor .
loading...
    loading...
Cat. No.: HY-I1120R
CAS No.: 864070-37-1
Research Areas:  

Metabolic Disease

SGLT2-IN-1 (standard) is the analytical standard for SGLT2-IN-1. This product is used for research and analytical applications. SGLT2-IN-1 (Compound 5) is an inhibitor for sodium-dependent glucose cotransporter (SGLT2), with IC50 of 33 nM in CHO cells transfected with human SGLT2. SGLT2-IN-1 is selective for SGLT2 over SGLT1. SGLT2-IN-1 is an active metabolite of dapagliflozinactive metabolite of dapagliflozin.
loading...
    loading...
Cat. No.: HY-186207
CAS No.: 2408732-62-5
Target:  

SGLT

Research Areas:  

Metabolic Disease

Demethyl-LX2761 is a selective sodium-glucose cotransporter 1 (SGLT1) inhibitor. Demethyl-LX2761 can be used for the research of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-10449R
CAS No.: 898537-18-3
Synonyms: TS 071 (Standard)
Research Areas:  

Metabolic Disease

Luseogliflozin (Standard) is the analytical standard of Luseogliflozin (HY-10449). This product is intended for research and analytical applications. Luseogliflozin (TS 071) is a potent, selective, orally active sodium-dependent glucose cotransporter (SGLT) 2 inhibitor, with an IC50 of 2.26 nM, about 1765-fold selectivity over SGLT1 (IC50, 3990 nM). Luseogliflozin has the protential for researching type 2 diabetes .
loading...
    loading...
Cat. No.: HY-180527
Research Areas:  

Metabolic Disease

SGLT2-IN-5 (Compound 99) is an orally active SGLT2 inhibitor with IC₅₀ values for SGLT2, SGLT1, and DPP4 of 0.8, 23, and 58 nM respectively. SGLT2-IN-5 controls blood sugar levels in diabetic rat models and increases the levels of active GLP-1. SGLT2-IN-5 can be used for the study of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-180528
Research Areas:  

Metabolic Disease

SGLT2-IN-6 (Compound 101) is an orally active SGLT2 inhibitor with IC₅₀ values for SGLT2, SGLT1, and DPP4 of 0.8, 6.7, and 72 nM respectively. SGLT2-IN-6 controls blood sugar levels in diabetic rat models and increases the levels of active GLP-1. SGLT2-IN-6 can be used for the study of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-180784
Hypoglycemic agent 4 (Compound 5b) is a tetrahydroacridine derivative with orally active hypoglycemic activity. Hypoglycemic agent 4 has a good binding affinity for the key diabetic targets: DPP-IV, SGLT1, and GLUT2. Hypoglycemic agent 4 can inhibit glucose diffusion. Hypoglycemic agent 4 can reduce fasting blood sugar in Streptozotocin (HY-13753)-induced diabetic rats and its effect is comparable to Gliclazide (HY-B0753). Hypoglycemic agent 4 can be used for research of type 2 diabetes .
loading...
    loading...
  • 1